Ocugen Inc
NASDAQ:OCGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ocugen Inc
NASDAQ:OCGN
|
US |
|
S
|
Sana Biotechnology Inc
NASDAQ:SANA
|
US |
|
N
|
Nice Ltd
TASE:NICE
|
IL |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
Pitney Bowes Inc
NYSE:PBI
|
US |
|
Tower Resources PLC
LSE:TRP
|
UK |
Wall St Price Targets
OCGN Price Targets Summary
Ocugen Inc
According to Wall Street analysts, the average 1-year price target for
OCGN is 11.37 USD with a low forecast of 7.07 USD and a high forecast of 23.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OCGN's stock price target?
Price Target
11.37
USD
According to Wall Street analysts, the average 1-year price target for
OCGN is 11.37 USD with a low forecast of 7.07 USD and a high forecast of 23.1 USD.
What is the Revenue forecast for Ocugen Inc?
Projected CAGR
126%
Over the last 13 years, the compound annual growth rate for Revenue has been 47%. The projected CAGR for the next 8 years is 126%.